Silica-coated flexible liposomes as a nanohybrid delivery system for enhanced oral bioavailability of curcumin

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 5995-6002

  Li, Chong ^a   Zhang, Yan ^a   Su, Tingting ^a   Feng, Lianlian ^a   Long, Yingying ^a   Chen, Zhangbao ^a  

^a SOUTHWEST UNIVERSITY   (China)

Author keywords

Curcumin; Flexible liposome; Oral bioavailability; Silica

Indexed keywords

CURCUMIN; LIPOSOME; SILICON DIOXIDE; BIOMATERIAL; NANOCAPSULE;

ARTICLE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG FORMULATION; DRUG STABILITY; IN VITRO STUDY; INTESTINE FLUID; STOMACH JUICE; SUSTAINED DRUG RELEASE; ANIMAL; BIOAVAILABILITY; CHEMISTRY; HARDNESS; METABOLIC CLEARANCE RATE; ORAL DRUG ADMINISTRATION; RAT; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE; YOUNG MODULUS;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; COATED MATERIALS, BIOCOMPATIBLE; CURCUMIN; ELASTIC MODULUS; HARDNESS; LIPOSOMES; METABOLIC CLEARANCE RATE; NANOCAPSULES; RATS; RATS, SPRAGUE-DAWLEY; SILICON DIOXIDE;

EID: 84875863240     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S38043     Document Type: Article

References (42)

1. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005;4:145-160.
2. Ying X, Wen H, Lu WL, et al. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. J Control Release. 2010;141:183-192.
3. Qin Y, Chen H, Zhang Q, et al. Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals. Int J Pharm. 2011;420:304-312.
4. Fricker G, Kromp T, Wendel A, et al. Phospholipids and lipid-based formulations in oral drug delivery. Pharm Res. 2010;27:1469-1486.
5. Rogers JA, Anderson KE. The potential of liposomes in oral drug delivery. Crit Rev Ther Drug Carrier Syst. 1998;15:421-480.
6. Chen Y, Lu Y, Chen J, et al. Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt. Int J Pharm. 2009;376:153-160.
7. Parmentier J, Becker MM, Heintz U, et al. Stability of liposomes containing bio-enhancers and tetraether lipids in simulated gastro-intestinal fluids. Int J Pharm. 2011;405:210-217.
8. Ariën A, Goigoux C, Baquey C, et al. Study of in vitro and in vivo stability of liposomes loaded with calcitonin or indium in the gastrointestinal tract. Life Sci. 1993;53:1279-1290.
9. Chiang CM, Weiner N. Gastrointestinal uptake of liposomes. I. In vitro and in situ studies. Int J Pharm. 1987;37:75-85.
10. Minato S, Iwanaga K, Kakemi M, et al. Application of polyethyleneglycol (PEG)-modified liposomes for oral vaccine: effect of lipid dose on systemic and mucosal immunity. J Control Release. 2003;89:189-197.
11. Li H, Song JH, Park JS, et al. Polyethylene glycol-coated liposomes for oral delivery of recombinant human epidermal growth factor. Int J Pharm. 2003;258:11-19.
12. Sihorkar V, Vyas1 SP. Potential of polysaccharide anchored liposomes in drug delivery, targeting and immunization. J Pharm Pharmaceut Sci. 2001;4:138-158.
13. Mu X, Zhong Z. Preparation and properties of poly(vinyl alcohol)-stabilized liposomes. Int J Pharm. 2006;318:55-61.
14. Takeuchi H, Yamamoto H, Toyoda T, et al. Physical stability of size controlled small unilameller liposomes coated with a modified polyvinyl alcohol. Int J Pharm. 2006;318:55-61.
15. Begu S, Aubert-Pouessel A, Lerner DA, et al. Liposil, a promising composite material for drug storage and release. J Control Release. 2007;118:1-6.
16. Qi JJ, Yue XL, Wang Y, et al. Encapsulation and relese of doxorubicin form silica-coated liposome. J Clin Rehab Tissue Eng Res. 2009;13: 4185-4188.
17. Bégu S, Durand R, Lerner DA, et al. Preparation and characterization of siliceous material using liposomes as template. Chem Commun. 2003;7:640-641.
18. Dwivedi N, Arunagirinathan MA, Sharma S, et al. Silica-coated liposomes for insulin delivery. J Nanomaterials. 2010;Article ID 652048, doi:10.1155/2010 /652048.
19. Cevc G, Schätzlein A, Richardsen H. Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers intact. Evidence from double label clsm experiments and direct size measurements. Biochim Biophys Acta. 2002;1564:21-30.
20. Cevc G. Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev. 2004;56:675-711.
21. Porter CJ, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov. 2007;6:231-248.
22. Andrieux K, Forte L, Lesieur S, et al. Solubilisation of dipalmitoyl phosphatidyl-choline bilayers by sodium taurocholate: a model to study the stability of liposomes in the gastrointestinal tract and their mechanism of interaction with a model bile salt. Eur J Pharm Biopharm. 2009;71:346-355.
23. Niu MM, Lu Y, Hovgaard L, et al. Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation. Int J Nanomedicine. 2011;6:1155-1166.
24. Guan PP, Lu Y, Qi JP, et al. Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt. Int J Nanomedicine. 2011;6:965-974.
25. Sun J, Deng Y, Wang S, et al. Liposomes incorporating sodium deoxycholate for hexamethylmelamine (HMM) oral delivery: development, characterization, and in vivo evaluation. Drug Deliv. 2010;17:164-170.
26. Christophe B, John B, Linggen K, et al. Silica particles: a novel drug-delivery system. Adv Mater. 2004;16:1-8.
27. Timo L, Christophe J, Jens M, et al. Nanostructured silica materials as drug-delivery systems for doxorubicin: single molecule and cellular studies. Nano Lett. 2009;9:2877-2883.
28. Zhang Y, Wang J, Bai X, et al. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs. Mol Pharm. 2012;9:505-513.
29. Pan L, He Q, Liu J, et al. Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles. J Am Chem Soc. 2012;134:5722-5725.
30. Folliet N, Roiland C, Bégu S, et al. Investigation of the interface in silica-encapsulated liposomes by combining solid state NMR and first principles calculations. J Am Chem Soc. 2011;133:16815-16827.
31. Cavallaro G, Manna GL, Liveri VT, et al. Structural investigation of Water/ Lecithin/ Cyclohexane Microemulsions by FT-IR Spectroscopy. J Colloid Interf Sci. 1995;176:281-285.
32. Dreher F, Walde P, Walther P, et al. Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport. J Control Release. 1997;45:131-140.
33. Das RK, Kasoju N, Bora U. Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomedicine. 2009;6:153-160.
34. Belkacemi A, Doggui S, Dao L, et al. Challenges associated with curcumin therapy in Alzheimer disease. Expert Rev Mol Med. 2011;13:e34.
35. Parvathya KS, Negib PS, Srinivasa P, Curcumin-amino acid conjugates: Synthesis, antioxidant and antimutagenic attributes. Food Chem. 2010;120:523-530.
36. Yadav VR, Suresh S, Devi K, et al. Effect of cyclodextrin complexation of curcumin on its solubility and antiangiogenic and anti-inflammatory activity in rat colitis model. AAPS Pharm Sci Tech. 2009;10:752-762.
37. Tang H, Murphy CJ, Zhang B, et al. Amphiphilic curcumin conjugate-forming nanoparticles as anticancer prodrug and drug carriers: in vitro and in vivo effects. Nanomedicine. 2010;5:855-865.
38. Tsai YM, Chang-Liao WL, Chien CF, et al. Effects of polymer molecular weight on relative oral bioavailability of curcumin. Int J Nanomedicine. 2012;7:2957-2966.
39. Takahashi M, Uechi S, Takara K, et al. Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated Curcumin. J Agric Food Chem. 2009;57:9141-9146.
40. Zhongfa L, Chiu M, Wang J, et al. Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice. Cancer Chemother Pharmacol. 2012;69:679-689.
41. Cui J, Yu B, Zhao Y, et al. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm. 2009;371:148-155.
42. Wang K, Zhang T, Liu L, et al. Novel micelle formulation of curcumin for enhancing antitumor activity and inhibiting colorectal cancer stem cells. Int J Nanomedicine. 2012;7:4487-4497.